These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 3769175)
21. [A study from Navarra. Hyperlipidemias. Avarage scores and percentiles for lipids and lipoproteins in a population of children and adolescents. Correlation with anthropometric parameters]. Elcarte López R; Villa-Elizaga I; Sada Goñi J; Gasco Eguiluz M; Oyarzábal Irigoyen M; Sola Mateos A; García Ibero C; Elcarte López T; Ferrer Giménez M; Fontaneda Estíbaliz A An Esp Pediatr; 1993 Apr; 38(4):307-15. PubMed ID: 8480942 [TBL] [Abstract][Full Text] [Related]
22. A physician's guide to hyperlipidemia. Fredrickson DS Mod Concepts Cardiovasc Dis; 1972 Jul; 41(7):31-6. PubMed ID: 4343098 [No Abstract] [Full Text] [Related]
23. Clues to the diagnosis of hyperlipoproteinemia. Scheig R Am Fam Physician; 1972 Nov; 6(5):82-5. PubMed ID: 4343861 [No Abstract] [Full Text] [Related]
24. [Hyperlipoproteinemias in childhood]. Czerny B Kinderarztl Prax; 1978 Nov; 46(11):561-9. PubMed ID: 366234 [No Abstract] [Full Text] [Related]
25. Pediatric familial type IV hyperlipoproteinemia. Glueck CJ; Tsang R; Fallat R; Ford S; Evans G; Beckett D; Steiner P Trans Assoc Am Physicians; 1972; 85():139-50. PubMed ID: 4660006 [No Abstract] [Full Text] [Related]
26. Management of dyslipidemia. Akel MM; Salti I J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421 [No Abstract] [Full Text] [Related]
27. [Primary hyperlipoproteinemia from its clinical and laboratory aspects. I. Patient data in the light of anamestic and subjective symptoms]. Olejak B; Szmatłoch E; Gregorczyk J; Cwajda H; Pieczul-Mróz J; Ansilewski K; Kornacewicz-Jach Z; Brzeźniak R Przegl Lek; 1983; 40(9):671-6. PubMed ID: 6665224 [No Abstract] [Full Text] [Related]
28. [Arteriosclerosis. III. Laboratory diagnosis of dyslipoproteinemia]. Nowicka G; Kłosiewicz-Latoszek L Wiad Lek; 1985 Aug; 38(16):1179-84. PubMed ID: 4082589 [No Abstract] [Full Text] [Related]
29. Diagnosis and treatment of Type II and Type IV hyperlipoproteinemia in the office practice setting. Millett F; Sielski J; Stoll H; Alston N; Gail S PA J; 1976; 6(2):54-9. PubMed ID: 10235781 [No Abstract] [Full Text] [Related]
31. Consideration of serum cholesterol in risk factor profiling for all young individuals. Berenson GS; Srinivasan SR Nutr Metab Cardiovasc Dis; 2001 Oct; 11 Suppl 5():1-9. PubMed ID: 12063769 [TBL] [Abstract][Full Text] [Related]
32. Serum lipids and lipoproteins in first degree relatives of young survivors of myocardial infarction. Aro A Acta Med Scand Suppl; 1973; 553():1-103. PubMed ID: 4550038 [No Abstract] [Full Text] [Related]
33. [Serum cholesterol in endogenous hyperlipidemia (type IV)]. Wille LE Tidsskr Nor Laegeforen; 1972 Nov; 92(31):2089-92. PubMed ID: 4656549 [No Abstract] [Full Text] [Related]
34. [Hyperlipoproteinemia--problems of diagnosis and treatment. Report of the Working Group of the Polish Cardiology Society]. Michajlik A; Ciświcka-Sznajderman M; Sznajd J; Szostak W Kardiol Pol; 1982; 25(12):1061-8. PubMed ID: 7169735 [No Abstract] [Full Text] [Related]
35. Hyperlipoproteinemia: diagnosis and management. Shakir KM Prim Care; 1976 Jun; 3(2):277-91. PubMed ID: 1047448 [TBL] [Abstract][Full Text] [Related]
36. Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriocslerosis. Gotto AM; Bierman EL; Connor WE; Ford CH; Frantz ID; Glueck CJ; Grundy SM; Little JA Circulation; 1984 May; 69(5):1065A-1090A. PubMed ID: 6398768 [No Abstract] [Full Text] [Related]
38. [Hyperlipoproteinemias in childhood]. Widhalm K Wien Med Wochenschr; 1994; 144(12-13):320-3. PubMed ID: 8650937 [TBL] [Abstract][Full Text] [Related]